Structural Characterization of the Self-Association of the Death Domain of p75NTR

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Qu, Qianhui ^a,b   Chen, Jun ^a,b   Wang, Yizhi ^a,b   Gui, Wenjun ^a,b   Wang, Li ^a,b   Fan, Zusen ^a   Jiang, Tao ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DIMER; NEUROTROPHIN; NEUROTROPHIN RECEPTOR P75; OLIGOMER; DISULFIDE; HYBRID PROTEIN; NERVE GROWTH FACTOR RECEPTOR; TNFRSF16 PROTEIN, RAT;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; COVALENT BOND; CRYSTAL STRUCTURE; DIMERIZATION; DISULFIDE BOND; OLIGOMERIZATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CELL MEMBRANE; CHEMISTRY; HEK293 CELL LINE; HUMAN; INTERFEROMETRY; METABOLISM; MOLECULAR GENETICS; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; RAT; SEQUENCE HOMOLOGY; SURFACE PLASMON RESONANCE; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; CYSTEINE; DIMERIZATION; DISULFIDES; HEK293 CELLS; HUMANS; INTERFEROMETRY; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, NERVE GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

EID: 84874617834     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057839     Document Type: Article

References (48)

1. Chao MV, (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nature Reviews Neuroscience 4: 299-309.
2. Reichardt LF, (2006) Neurotrophin-regulated signalling pathways. Philosophical Transactions of the Royal Society B: Biological Sciences 361: 1545.
3. Liepinsh E, Ilag LL, Otting G, Ibanez CF, (1997) NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J 16: 4999-5005.
4. Underwood CK, Coulson EJ, (2008) The p75 neurotrophin receptor. The International Journal of Biochemistry & Cell Biology 40: 1664-1668.
5. Frossard N, Freund V, Advenier C, (2004) Nerve growth factor and its receptors in asthma and inflammation. European Journal of Pharmacology 500: 453-465.
6. Hempstead BL, (2002) The many faces of p75NTR. Curr Opin Neurobiol 12: 260-267.
7. Roux PP, Barker PA, (2002) Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 67: 203-233.
8. Nykjaer A, Willnow TE, Petersen CM, (2005) p75NTR-live or let die. Curr Opin Neurobiol 15: 49-57.
9. Ben-Zvi A, Ben-Gigi L, Klein H, Behar O, (2007) Modulation of semaphorin3A activity by p75 neurotrophin receptor influences peripheral axon patterning. The Journal of Neuroscience 27: 13000.
10. Lim YS, McLaughlin T, Sung TC, Santiago A, Lee KF, et al. (2008) p75NTR mediates ephrin-A reverse signaling required for axon repulsion and mapping. Neuron 59: 746-758.
11. Coulson EJ, Reid K, Bartlett PF, (1999) Signaling of neuronal cell death by the p75NTR neurotrophin receptor. Mol Neurobiol 20: 29-44.
12. Blochl A, Blochl R, (2007) A cell-biological model of p75NTR signaling. J Neurochem 102: 289-305.
13. Krygier S, Djakiew D, (2001) The neurotrophin receptor p75NTR is a tumor suppressor in human prostate cancer. Anticancer Res 21: 3749-3755.
14. Allen J, Khwaja F, Djakiew D, (2004) Gene therapy of prostate xenograft tumors with a p75NTR lipoplex. Anticancer Res 24: 2997-3003.
15. Nordell VL, Lewis DK, Bake S, Sohrabji F, (2005) The neurotrophin receptor p75NTR mediates early anti-inflammatory effects of estrogen in the forebrain of young adult rats. BMC Neurosci 6: 58.
16. Zhou XF, Li HY, (2007) Roles of glial p75NTR in axonal regeneration. J Neurosci Res 85: 1601-1605.
17. Fujii T, Kunugi H, (2009) p75NTR as a therapeutic target for neuropsychiatric diseases. Curr Mol Pharmacol 2: 70-76.
18. Zeng F, Lu JJ, Zhou XF, Wang YJ, (2011) Roles of p75NTR in the pathogenesis of Alzheimer's disease: A novel therapeutic target. Biochem Pharmacol.
19. Gong Y, Cao P, Yu HJ, Jiang T, (2008) Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex. Nature 454: 789-793.
20. Feng D, Kim T, Ozkan E, Light M, Torkin R, et al. (2010) Molecular and structural insight into proNGF engagement of p75NTR and sortilin. J Mol Biol 396: 967-984.
21. Wang JJ, Rabizadeh S, Tasinato A, Sperandio S, Ye X, et al. (2000) Dimerization-dependent block of the proapoptotic effect of p75NTR. J Neurosci Res 60: 587-593.
22. Vilar M, Charalampopoulos I, Kenchappa RS, Simi A, Karaca E, et al. (2009) Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron 62: 72-83.
23. Mi W, Li L, Su XD, (2008) 5, 5′-Dithio-bis (2-nitrobenzoic acid) modification of cysteine improves the crystal quality of human chloride intracellular channel protein 2. Biochemical and Biophysical Research Communications 368: 919-922.
24. Yamashita T, Tohyama M, (2003) The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 6: 461-467.
25. Park HH, Lo YC, Lin SC, Wang L, Yang JK, et al. (2007) The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annual Review of Immunology 25: 561.
26. Xiao T, Towb P, Wasserman SA, Sprang SR, (1999) Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell 99: 545-555.
27. Park HH, Logette E, Raunser S, Cuenin S, Walz T, et al. (2007) Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 128: 533-546.
28. Scott FL, Stec B, Cristina Pop M, (2008) The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 457: 1019-1022.
29. Lin SC, Lo YC, Wu H, (2010) Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465: 885-890.
30. Wang L, Yang JK, Kabaleeswaran V, Rice AJ, Cruz AC, et al. (2010) The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nature Structural & Molecular Biology 17: 1324-1329.
31. Weber CH, Vincenz C, (2001) A docking model of key components of the DISC complex: death domain superfamily interactions redefined. FEBS letters 492: 171-176.
32. Krissinel E, Henrick K, (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774-797.
33. Bailey S, (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D 50: 760-763.
34. Casademunt E, Carter BD, Benzel I, Frade JM, Dechant G, et al. (1999) The zinc finger protein NRIF interacts with the neurotrophin receptor p75(NTR) and participates in programmed cell death. EMBO J 18: 6050-6061.
35. Linggi MS, Burke TL, Williams BB, Harrington A, Kraemer R, et al. (2005) Neurotrophin receptor interacting factor (NRIF) is an essential mediator of apoptotic signaling by the p75 neurotrophin receptor. J Biol Chem 280: 13801-13808.
36. Esposito D, Sankar A, Morgner N, Robinson CV, Rittinger K, et al. (2010) Solution NMR investigation of the CD95/FADD homotypic death domain complex suggests lack of engagement of the CD95 C terminus. Structure 18: 1378-1390.
37. Khursigara G, Bertin J, Yano H, Moffett H, DiStefano PS, et al. (2001) A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J Neurosci 21: 5854-5863.
38. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J, (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125: 1137-1149.
39. Tyurina YY, Nylander KD, Mirnics ZK, Portugal C, Yan C, et al. (2005) The intracellular domain of p75NTR as a determinant of cellular reducing potential and response to oxidant stress. Aging Cell 4: 187-196.
40. Mi Z, Rogers DA, Mirnics ZK, Schor NF, (2009) p75NTR-dependent modulation of cellular handling of reactive oxygen species. J Neurochem 110: 295-306.
41. Battye TGG, Kontogiannis L, Johnson O, Powell HR, Leslie AGW, (2011) iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallographica Section D: Biological Crystallography 67: 271-281.
42. Otwinowski Z, Minor W, (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods in Enzymology 276: 307-326.
43. Vagin A, Teplyakov A, (1997) MOLREP: an automated program for molecular replacement. Journal of Applied Crystallography 30: 1022-1025.
44. Pranovich S, Achten H, de Vries B, van Wijk J, (2005) Structural Sketcher: Representing and applying well-structured graphic representations in early design. International Journal of Architectural Computing 3: 75-92.
45. Perrakis A, Harkiolaki M, Wilson KS, Lamzin VS, (2001) ARP/wARP and molecular replacement. Acta Crystallographica Section D: Biological Crystallography 57: 1445-1450.
46. Murshudov G, Vagin AA, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallographica Section D: Biological Crystallography 53: 240-255.
47. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallographica Section D: Biological Crystallography 60: 2126-2132.
48. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 26: 283-291.